Transcription and Translation Inhibitors in Cancer Treatment
Author:
Funder
Maire Taposen Säätiö
Academy of Finland
Technology Agency of the Czech Republic
Publisher
Frontiers Media SA
Subject
General Chemistry
Reference271 articles.
1. TAS-106: preclinical, clinical and beyond;Abdelrahim;Oncology,2013
2. Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy;Alqahtani;Future Sci.,2019
3. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality;Arkin;Chem. Biol.,2014
4. Assessment of the evolution of cancer treatment therapies;Arruebo;Cancers,2011
5. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug. Discov.,2015
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Suppression by RNA Polymerase I Inhibitors Varies Greatly Between Distinct RNA Polymerase I Transcribed Genes in Malaria Parasites;2024-09-02
2. Formulation, Characterization, and Potential Therapeutic Implications of Encapsulated Recombinant Alpha-Luffin in Niosomes;Current Pharmaceutical Biotechnology;2024-08-23
3. Pleomorphic adenoma and carcinoma ex‐pleomorphic adenoma tumorigenesis: A proteomic analysis;Oral Diseases;2024-08-18
4. Development of small molecule–drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells;Bioorganic & Medicinal Chemistry;2024-06
5. Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition;ELIFE;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3